SPRINT proves that lower is better for nondiabetic high-risk patients, but at a price

American Journal of Hypertension

Volumn 29, Issue 1, 2016, Pages 2-4

  Schiffrin, Ernesto L ^a,b   Calhoun, David A ^c   Flack, John M ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMAN; HYPERTENSION; MEDICAL SOCIETY; MIDDLE AGED; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

AGED; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; MIDDLE AGED; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 84954552821     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv190     Document Type: Editorial

References (7)

1. SPRINT Study Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015; 373: 2103-2116
2. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Williamson JD, Wright JT Jr, Whelton PK. SPRINT Study Research Group. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014; 11: 532-546
3. Accord Study Group. Effects of intensive blood pressure control in type 2 diabetes. New Engl J Med 2010; 362: 1575-1585
4. Leenen FH, Schiffrin EL. Control rates of hypertension in North America. Hypertension 2010; 56: 571-572
5. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension 2010; 55: 195-200
6. Myers MG, Kaczorowski J, Paterson JM, Dolovich L, Tu K. Thresholds for diagnosing hypertension based on automated office blood pressure measurements and cardiovascular risk. Hypertension 2015; 66: 489-495
7. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665